Lactate Clearance According to the Presence of Hepatic Dysfunction
Status
Conditions
Details and patient eligibility
About
The purpose of this study is to compare lactate clearance in patients with severe sepsis and septic shock according to the presence of hepatic dysfunction.
Full description
Lactate clearance is well known to be associated with mortality in patients with severe sepsis and septic shock. To normalize lactate levels is one of important goals of early resuscitation of sepsis patients.
Lactate clearance can be changed by various factors including patient characteristics, severity of shock, and treatment. In particular, hepatic dysfunction might impair the clearance of lactate because liver is a principal organ for lactate metabolism. However, an association between lactate clearance and hepatic failure has not been evaluated during initial resuscitation of patients with severe sepsis and septic shock. The primary goal of this study is to compare lactate clearance in patients with severe sepsis and septic shock according to the presence of hepatic dysfunction. The secondary goal is to evaluate if lactate clearance is associated with mortality even in patients with hepatic dysfunction.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients who presented with septic shock or severe sepsis within 6 hours after emergency department arrival
Exclusion criteria
- Terminal malignancy or illness with a expected survival < 4 months
- Patients who previously signed "Do Not Resuscitate" or "Do Not Intubate" orders
- Patients who do not undergo the early goal-directed therapy
Trial design
245 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Ik Joon Jo, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal